Back to results
US 2010/0063303 A1Published application
Therapeutic compounds
AssigneeAllergan, Inc.
InventorsMark Holoboski, Robert M. Burk, Mari F. Posner
Life of this patent
Estimating the term…
Abstract
Compound having the formula below are disclosed herein: formula (I). Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
Claims35
A compound having the formula
- or a pharmaceutically acceptable salt, thereof;
- wherein Y is an organic acid functional group, or an amide or ester thereof comprising up to 14 carbon atoms;
- or Y is hydroxymethyl or an ether thereof comprising up to 14 carbon atoms;
- or Y is a tetrazolyl functional group;
- A is —(CH2)6—, cis-CH2CH═—CH—(CH2)3—, or —CH2C≡C—(CH2)3—, wherein 1 or 2 carbon atoms may be replaced by S or O;
- or A is —(CH2)m—Ar—(CH2)o— wherein Ar is interarylene or heterointerarylene, the sum of m and o is 1, 2, 3, or 4, and wherein one CH2 may be replaced by S or O;
- R1 is CN or OH;
- R2 is H, CN, OH, F, Cl, Br, or CH3 with the proviso that if R1 is OH, R2 is not OH;
- Z is —CH2CHOH, CHOHCH2, or CHOH;
- G is L, —CH2L, OL, or SL;
- L is phenyl, monocyclic heteroaryl, or C1-6 alkyl.
8 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.